The National Heart, Lung and Blood Institute has awarded the Palo Alto Medical Foundation Research Institute (PAMFRI) a $1.7M three-year grant (R01HL119845) to study a new way to measure the effects of a disease and its treatment on patients’ lives. The study will focus on asthma to test the new approach.
Many tools already exist to help physicians and scientists measure patients’ symptoms, physical limitations and emotional well-being. However, “These measures alone don’t tell physicians caring for patients or scientists developing new medical treatments how the patient feels their quality of life is being affected, says , PAMFRI senior scientist and the study’s principal investigator. “Getting that information requires a new type of measure.”
Study on Benefits of Strength Training Regimen for Normal Weight Diabetics
Researchers at the Palo Alto Medical Foundation Research Institute (PAMFRI) have been awarded a $3M grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study the benefits of strength training for people with type 2 diabetes who are at normal weight.
With type 2 diabetes, the body cannot use insulin properly to control blood sugar levels. Regular physical activity has been shown to help control blood sugar levels, and current guidelines emphasize aerobic exercise and weight loss for overweight individuals with type 2 diabetes. However, up to one in five people with type 2 diabetes are at normal weight, with a body mass index (BMI) under 25. They may not need to lose weight. For these individuals, best exercise regimen is not yet known. There is evidence that strength training, which improves muscle mass while decreasing body fat, may be more beneficial for normal weight diabetics than other types of exercise. Read More about NIH Awards $3M Grant to PAMF Research Institute
Seventy-four percent of employers who offer health insurance also offer an employee wellness program. Options such as smoking cessation groups and walking programs encourage employees to set and achieve health goals in exchange for discounted health insurance premiums. In January 2014, the government allowed employers to increase the incentive discount, from 20 percent to 30 percent of the total health insurance premium cost.
But do employee wellness programs actually work? The Palo Alto Medical Foundation Research Institute (PAMFRI) recently published a commentary in the American Journal of Preventive Medicine on this question.
According to Lenard Lesser, M.D., MSHS, PAMFRI Assistant Research Physician, while monetary incentives may help employees start to make changes, sustaining those changes in the long term is far more challenging.
Researchers at the Palo Alto Medical Foundation Research Institute (PAMFRI) are exploring a new and creative way to manage Type 2 diabetes in South Asian immigrants. For the first time, Bollywood dance – a high-energy, cinematic dance style native to India –will be studied for its effectiveness in managing diabetes.
In comparison to all other racial and ethnic groups, South Asians in the United States have one of the highest rates of type 2 diabetes. For this group, encouraging lifestyle changes, such as increasing exercise and making healthier eating choices, are an essential part of diabetes care.
Amlu Natesan, a UC Berkeley-UCSF Joint Medical Program student, has partnered with PAMFRI’s Latha Palaniappan, M.D., M.S. and her research team and the India Community Center (ICC) to address this issue. The Culturally Relevant Exercise for Type 2 Diabetes (CURE-D) study is piloting an innovative Bollywood exercise program in an effort to motivate and engage South Asian women in exercise.
More than three million Americans suffer from severe emphysema, a form of COPD (Chronic Obstructive Pulmonary Disease). This chronic, debilitating disease causes irreversible damage to delicate lung tissue, leading to shortness of breath and reduced capacity to manage activities of daily living, leading to diminished quality of life.
The Palo Alto Medical Foundation is collaborating with El Camino Hospital and Fogarty Clinical Research Inc. to conduct a clinical trial to evaluate the investigational use of the RePneu® (pronounced ‘RENEW’) Lung Volume Reduction Coil (LVRC) for patients experiencing symptoms of emphysema. Read More about RENEW Clinical Trial – Evaluating a Treatment for Patients with Emphysema
Lowering medical costs while improving care cannot be achieved unless improvements in healthcare efficiency made at a few pilot sites of an organization can be adopted at all sites. Recognizing this, the Agency for Healthcare Research & Quality (AHRQ) has issued a contract valued at more than $750,000 to the Palo Alto Medical Foundation Research Institute (PAMFRI). The money will fund a study led by Dorothy Hung, Ph.D., M.A., MPH, assistant scientist at PAMFRI, to analyze and disseminate PAMF’s effort to implement the “Lean” management system across the entire organization. This contract leverages ongoing work that Dr. Hung and her team are conducting as part of an internal evaluation of Lean at PAMF. Read More about PAMF Research Institute Wins AHRQ Grant to Study Efficiency Across Large Healthcare Systems